Yeast (1 -> 3)-(1 -> 6)-beta-D-glucan alleviates immunosuppression in gemcitabine-treated mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chae, Jin Sung | - |
dc.contributor.author | Shin, Hocheol | - |
dc.contributor.author | Song, Youngju | - |
dc.contributor.author | Kang, Hee | - |
dc.contributor.author | Yeom, Chang-Hwan | - |
dc.contributor.author | Lee, Sukchan | - |
dc.contributor.author | Choi, Youn Seon | - |
dc.date.accessioned | 2021-09-01T07:16:35Z | - |
dc.date.available | 2021-09-01T07:16:35Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-09-01 | - |
dc.identifier.issn | 0141-8130 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62948 | - |
dc.description.abstract | Gemcitabine (2'-deoxy-2',2'-difluorocytidine, dFdC) is one of the most effective chemotherapy drugs commonly used for treatment of various tumors. Despite its significant anticancer effects, some adverse effects create obstacles to treatment. The main toxicity of gemcitabine is myelosuppression, which not only reduces patient quality of life, but also hinders further anticancer treatment. In this respect, immunotherapy can address these drawbacks because of its ability to enhance the patient's immune system. To improve immune system function, yeast-derived beta-glucans, which are well-known biologic response modifiers, were administered to gemcitabine-treated mice. The in vivo experiment revealed that orally administered yeast (1 -> 3)-(1 -> 6)-beta-glucan effectively alleviated myelosuppression associated with gemcitabine-induced pancytopenia. Moreover, analysis of myelopoiesis-related cytokine expression through real-time PCR demonstrated that beta-glucan treatment significantly upregulated hematopoietic responses in gemcitabine-treated mice. Furthermore, orally administered beta-glucan significantly induced the expression of IFN-gamma, and IL-2 in splenocytes of gemcitabinetreated mice. It also restored the cytotoxicity of splenocytes against YAC-1 in gemcitabine-treated mice and displayed a positive effect on gemcitabine-damaged bone marrow tissue. In conclusion, yeast beta-glucans have the potential to be used as adjuvants for alleviating chemotherapy-induced immunosuppression in patients. (C) 2019 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER | - |
dc.subject | ANTITUMOR IMMUNE-RESPONSES | - |
dc.subject | BINDING-PROTEIN | - |
dc.subject | DENDRITIC CELLS | - |
dc.subject | TUMOR | - |
dc.subject | TOXICITY | - |
dc.subject | BETA-1 | - |
dc.subject | PARTICULATE | - |
dc.subject | EFFICACY | - |
dc.subject | INNATE | - |
dc.title | Yeast (1 -> 3)-(1 -> 6)-beta-D-glucan alleviates immunosuppression in gemcitabine-treated mice | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Youn Seon | - |
dc.identifier.doi | 10.1016/j.ijbiomac.2019.06.009 | - |
dc.identifier.scopusid | 2-s2.0-85068230321 | - |
dc.identifier.wosid | 000482533000120 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, v.136, pp.1169 - 1175 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | - |
dc.citation.title | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | - |
dc.citation.volume | 136 | - |
dc.citation.startPage | 1169 | - |
dc.citation.endPage | 1175 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Polymer Science | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
dc.relation.journalWebOfScienceCategory | Polymer Science | - |
dc.subject.keywordPlus | ANTITUMOR IMMUNE-RESPONSES | - |
dc.subject.keywordPlus | BINDING-PROTEIN | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | TUMOR | - |
dc.subject.keywordPlus | TOXICITY | - |
dc.subject.keywordPlus | BETA-1 | - |
dc.subject.keywordPlus | PARTICULATE | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | INNATE | - |
dc.subject.keywordAuthor | Gemcitabine | - |
dc.subject.keywordAuthor | Hematopoiesis | - |
dc.subject.keywordAuthor | Immunosuppression | - |
dc.subject.keywordAuthor | Insoluble yeast beta-glucan | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.